Research Articles | Page 14 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Activity of luspatercept and ESAs combination for treatment of anemia in lower-risk myelodysplastic syndromes Apr 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Outpatient subcutaneous alemtuzumab is feasible and safe for aplastic anemia and is associated with high response rates Feb 2025 Blood Advances Aplastic Anemia
Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse Jul 2020 Blood Advances Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Modified Delphi Panel Consensus Recommendations for Management of Severe Aplastic Anemia Apr 2024 Blood Advances Aplastic Anemia
An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS Jun 2023 Blood Advances Myelodysplastic Syndromes (MDS)
Baseline and serial molecular profiling predicts outcomes with hypomethylating agents in myelodysplastic syndromes Feb 2021 Blood Advances Myelodysplastic Syndromes (MDS)
Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors Feb 2021 Blood Advances Myelodysplastic Syndromes (MDS)
ESCALATing care? Eltrombopag in pediatric aplastic anemia Aug 2025 Blood Advances Aplastic Anemia
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies Oct 2023 Blood Advances Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN)
Towards a Conceptualization of Measurable Residual Disease in Myelodysplastic Syndromes Jun 2023 Blood Advances Myelodysplastic Syndromes (MDS)